- Home
- SNY vs FINW Comparison
SNY vs FINW Comparison
Compare SNY & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNY | FINW |
|---|---|---|
| Founded | 1994 | 1999 |
| Country | France | United States |
| Employees | 74846 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.7B | 194.1M |
| IPO Year | 2001 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SNY | FINW |
|---|---|---|
| Price | $40.82 | $11.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $53.72 | $16.33 |
| AVG Volume (30 Days) | ★ 2.1M | 33.1K |
| Earning Date | 10-30-2026 | 10-28-2026 |
| Dividend Yield | ★ 4.28% | N/A |
| EPS Growth | N/A | ★ 21.51 |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | N/A |
| Revenue This Year | $2.00 | $41.06 |
| Revenue Next Year | $6.29 | $15.47 |
| P/E Ratio | ★ $6.14 | $31.89 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $40.40 | $10.79 |
| 52 Week High | $52.68 | $20.25 |
Technical Indicators
Market Signals| Indicator | SNY | FINW |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 17.44 |
| Support Level | $41.19 | $10.79 |
| Resistance Level | $45.22 | $14.62 |
| Average True Range (ATR) | 0.46 | 0.46 |
| MACD | -0.09 | -0.12 |
| Stochastic Oscillator | 38.62 | 11.72 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.